Article
Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma.
Scientific reports - 24 Aug 2021
Akasu Masafumi, Shimada Shu, Kabashima Ayano, Akiyama Yoshimitsu, Shimokawa Masahiro, Akahoshi Keiichi, Kudo Atsushi, Yamaoka Shoji, Tanabe Minoru, Tanaka Shinji
Abstract excerpt
Comprehensive analysis of clinical samples has recently identified molecular and immunological classification of hepatocellular carcinoma (HCC), and the CTNNB1 (β-catenin)-mutated subtype exhibits distinctive characteristics of immunosuppressive tumor microenvironment. For clarifying the molecular mechanisms, we first established human and mouse HCC cells with exon 3 skipping of β-catenin, which promoted nuclear...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
